Status:
TERMINATED
Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Lead Sponsor:
New Mexico Cancer Research Alliance
Conditions:
Melanoma
Eligibility:
All Genders
18-95 years
Brief Summary
This project seeks to understand differences in the serum vitamin D levels and immune status in cutaneous malignant melanoma patients with different UV exposure histories in New Mexico.
Detailed Description
It is well established that ultraviolet radiation (UV) exposure is related to the development of melanoma. There is also evidence that immune reactions are altered after UV exposure in the skin (local...
Eligibility Criteria
Inclusion
- Resident of New Mexico
- Age between the 1 and 95
- Newly diagnosed with cutaneous invasive melanoma; any stage permitted (ICDO C44.0-9) between September 1, 2008 and December 31, 2011.
- SSM (superficial spreading melanoma) and NM (nodular melanoma) histological subtypes are allowed
- Access to a telephone or be able to participate in a personal interview at the clinic
- Physically and mentally competent to complete a 1-hour telephone or personal interview
Exclusion
- Ocular melanoma, LMM (lentigo maligna melanoma) or ALM (acral lentigo melanoma), and mucosal melanoma cases.
- No access to a telephone or is not able to meet with the interviewer.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00996827
Start Date
January 1 2009
End Date
December 1 2013
Last Update
June 18 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lovelace Women's Hospial
Albuquerque, New Mexico, United States, 87109
2
University of New Mexico
Albuquerque, New Mexico, United States, 87131